Gyre Therapeutics, Inc. (GYRE)

NASDAQ: GYRE · Real-Time Price · USD

8.16

+0.45 (5.84%)

At close: Mar 9, 2026, 4:00 PM EDT

8.28

+0.12 (1.47%)

After-hours: Mar 9, 2026, 6:28 PM EDT

Gyre Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 9, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	742	1,038	1,967	-
Market Cap Growth	-31.20%	-47.22%	-	-
Enterprise Value	683	1,050	1,946	-
Last Close Price	8.16	12.10	25.69	-
PE Ratio	208.48	85.93	-	-
PS Ratio	6.91	9.82	17.34	-
PB Ratio	7.28	10.55	25.07	-
P/TBV Ratio	7.64	16.85	-	-
P/FCF Ratio	256.10	-	113.23	-
P/OCF Ratio	191.30	-	75.99	-
EV/Sales Ratio	6.37	9.93	17.15	-
EV/EBITDA Ratio	47.55	58.96	95.72	-
EV/EBIT Ratio	56.74	64.73	101.27	-
EV/FCF Ratio	235.77	-	111.99	-
Debt / Equity Ratio	0.01	0.02	0.01	0.01
Debt / EBITDA Ratio	0.08	0.09	0.02	0.06
Debt / FCF Ratio	0.40	-	0.02	0.11
Net Debt / Equity Ratio	-0.43	-0.25	-0.42	-0.34
Net Debt / EBITDA Ratio	-4.10	-1.41	-1.63	-2.38
Net Debt / FCF Ratio	-20.33	4.21	-1.90	-4.32
Asset Turnover	0.75	0.87	1.13	-
Inventory Turnover	0.64	0.73	0.89	-
Quick Ratio	5.41	2.64	2.49	3.33
Current Ratio	6.20	3.32	2.85	4.06
Return on Equity (ROE)	10.02%	20.24%	-113.45%	-
Return on Assets (ROA)	5.29%	8.38%	11.93%	-
Return on Invested Capital (ROIC)	12.01%	21.08%	41.30%	8.85%
Return on Capital Employed (ROCE)	8.40%	15.30%	19.90%	12.70%
Earnings Yield	0.90%	1.16%	-4.72%	-
FCF Yield	0.39%	-0.57%	0.88%	-
Buyback Yield / Dilution	-24.46%	-55.39%	13.02%	-

Source: S&P Capital IQ. Standard template. Financial Sources.